Bronte, Giuseppe http://orcid.org/0000-0002-2306-2445
Conteduca, Vincenza
Landriscina, Matteo
Procopio, Antonio Domenico
Article History
Received: 25 July 2022
Revised: 28 October 2022
Accepted: 7 November 2022
First Online: 21 November 2022
Competing interests
: VC has served as a consultant/advisory board member for Janssen, Astellas, Merck, AstraZeneca, Amgen and Bayer and has received speaker honoraria or travel support from Astellas, Janssen, Ipsen, Bayer. The other authors declare no competing interests.